Skin Cancer Specialist Dr. Melissa Wilson Joins Sidney Kimmel Cancer Center

The Sidney Kimmel Cancer Center – Jefferson Health (SKCC) welcomes Melissa A. Wilson, MD, PhD, as a new Associate Professor of Medical Oncology. Dr. Wilson treats patients with skin cancers including melanoma, squamous cell carcinoma, basal cell carcinoma, and Merkel cell carcinoma. In addition to her clinical practice, Dr. Wilson leads clinical and translational research …


Dr. Ana María López to Lead Medical Oncology at SKCC Jefferson Health – Washington Township

Ana María López, MD, MPH, joins the Sidney Kimmel Cancer Center – Jefferson Health (SKCC) as the Vice Chair of Medical Oncology and Chief of Cancer Services at the Sidney Kimmel Cancer Center – Washington Township. Dr. López comes from the Huntsman Cancer Institute in Salt Lake City, where she was Director of Cancer Health …


Newlyweds Face Cancer Diagnosis Together

When newly married couple Lydia and Anikait Sharma moved to the United States in 2016, they were excited about their lives in a brand new country. The London, United Kingdom natives had recently moved across the ocean to Philadelphia for Anikait’s new job as a Director of Financial Planning and Analysis. Lydia took her time …


Wm. Kevin Kelly, DO, Elected as Co-Chair of NCI Steering Committee

Wm. Kevin Kelly, DO, leader of the Prostate Cancer Program and associate director of Clinical Research at the Sidney Kimmel Cancer Center at Jefferson Health (SKCC), has been elected to serve as medical oncology co-chair on the National Cancer Institute (NCI) Genitourinary Cancers Steering Committee (GUSC). The GUSC addresses the design, prioritization, and evaluation of …


Dr. Jeannie Hoffman-Censits leads Walk for Bladder Cancer

On Saturday, May 5, 2012 Jeannie Hoffman-Censits, M.D. led Team Jefferson from the Kimmel Cancer Center‘s Bluemle Life Sciences Building to Independence Hall. Dr. Hoffman-Censits teamed up with “the first national advocacy organization devoted to bladder cancer,” the Bladder Cancer Advocacy Network, to help raise public awareness of bladder cancer and much needed funding. Team …


Dr. Ronald Myers selected to chair Expert Working Group discussion

Ronald Myers, Ph.D., Professor of Medical Oncology and Director of the Division of Population Science at Thomas Jefferson University, has been selected to chair an Expert Working Group discussion at the World Endoscopy Organization meeting on May 18, 2012. The discussion entitled “Improving Population Engagement in Screening” is being held ahead of the DDW Conference …


New Clinical Trial: Cabazitaxel with Radiation and Hormone Therapy May Improve Prostate Cancer Survival

Jefferson’s Kimmel Cancer Center has started a Phase I clinical trial investigating the latest prostate cancer chemotherapy drug to extend survival, Cabazitaxel, in combination with radiation and hormone therapy. This first-of-its-kind multimodality approach could improve disease control and eventually survival for locally advanced prostate cancer patients. The single-center, open-label, non-randomized Phase I study of weekly Cabazitaxel …